Villers-lès-Nancy, 5 July 2023 - 6:00 p.m. (CET)

PRESS RELEASE

RESULTS OF THE VOTES ON THE RESOLUTIONS SUBMITTED

TO THE ORDINARY ANNUAL SHAREHOLDERS' MEETING

OF 29 JUNE 2023

Number of shares comprising the share capital: 15,174,125

Number of shares with voting rights: 15,032,834

Number of shares with voting rights possessed by shareholders presents or represented or having voted by mail: 13,046,120

That means a quorum of 86.78% of the 15,032,834 shares with voting rights: the Ordinary Annual General Meeting was able to deliberate.

The Ordinary Annual General Meeting was held on Thursday, 29 June 2023 at 5:30 p.m. at the Company's headquarters and approved the separate parent company and consolidated financial statements for the 2022 financial year. The results of the votes on the resolutions proposed at this meeting by the Board of Directors were as follows:

Resolutions

Results of the votes

Resolution adopted by:

▪

RESOLUTION ONE

-

13,044,237 votes in favour

Approval of the annual financial statements

-

0 vote against

-

1,883 abstentions

▪

RESOLUTION TWO

Resolution adopted by:

- 12,943,792 votes in favour

Discharge of directors and discharge of the Statutory

-

100,445 votes against

Auditors for the performance of their engagement

-

1,883 abstentions

Resolution adopted by:

▪

RESOLUTION THREE

-

13,044,237 votes in favour

Approval of the consolidated financial statements

-

0 vote against

-

1,883 abstentions

Resolution adopted by:

▪

RESOLUTION FOUR

-

13,046,120 votes in favour

Appropriation of earnings, setting the dividend

-

0 vote against

-

0 abstention

▪

RESOLUTION FIVE

Resolution adopted by (*):

- 12,983,939 votes in favour

Agreements and commitments governed by Articles L.

-

62,072 votes against

225-38 of the French Commercial Code

-

99 abstentions

Press Release 5 July 2023 - Results of the votes - 2

▪

RESOLUTION SIX

Resolution adopted by:

- 10,706,967 votes in favour

Renewal of Ms. Anne LHOTE's term of office as

-

2,339,153 votes against

Director

-

0 abstention

▪

RESOLUTION SEVEN

Resolution adopted by:

- 11,112,739 votes in favour

Renewal of Ms. Céline GRIS's term of office as

-

1,933,381 votes against

Independant Director

-

0 abstention

▪

RESOLUTION EIGHT

Resolution adopted by:

- 10,723,209 votes in favour

Renewal of Ms. Émilie LECOMTE's term of office as

-

2,322,911 votes against

Director

-

0 abstention

Resolution adopted by:

▪

RESOLUTION NINE

-

12,902,756 votes in favour

Appointment of a new Director

-

143,364 votes against

-

0 abstention

Resolution adopted by:

▪

RESOLUTION TEN

-

13,040,577 votes in favour

Appointment of a new Statutory Auditor

-

5,543 votes against

-

0 abstention

▪

RESOLUTION ELEVEN

Resolution adopted by:

Approval of the information on the compensation of

- 12,095,451 votes in favour

corporate officers paid in or granted for fiscal 2022

-

950,669 votes against

and mentioned in Article L. 22-10-9 of the French

-

0 abstention

Commercial Code

▪

RESOLUTION TWELVE

Resolution adopted by:

Approval of the components of compensation paid in

-

13,033,420 votes in favour

2022 to Mr. Thierry CHAPUSOT, Chairman of the

-

12,700 votes against

Board of Directors

-

0 abstention

▪

RESOLUTION THIRTEEN

Resolution adopted by:

Approval of the components of compensation paid in

-

10,746,386 votes in favour

2022 to Mr. Dominique PAUTRAT, Chief Executive

-

2,299,734 votes against

Officer

-

0 abstention

▪

RESOLUTION FOURTEEN

Resolution adopted by:

Approval of the components of compensation paid in

-

10,592,005 votes in favour

2022 to Mr. Denis SUPPLISSON, Deputy Chief

-

2,454,115 votes against

Executive Officer and then Chief Executive Officer

-

0 abstention

▪

RESOLUTION FIFTEEN

Resolution adopted by:

- 10,592,005 votes in favour

Approval of the components of compensation paid in

-

2,454,115 votes against

2022 to Mr. Grégoire DE ROTALIER, Deputy CEO

-

0 abstention

▪

RESOLUTION SIXTEEN

Resolution adopted by:

- 13,033,420 votes in favour

Approval of the compensation policy for the Chairman

-

12,700 votes against

of the Board of Directors for 2023

-

0 abstention

Press Release 5 July 2023 - Results of the votes - 3

▪

RESOLUTION SEVENTEEN

Resolution adopted by:

- 10,759,416 votes in favour

Approval of the compensation policy for Mr. Denis

-

2,286,704 votes against

SUPPLISSON, Chief Executive Officer, for 2023

-

0 abstention

▪

RESOLUTION EIGHTEEN

Resolution adopted by:

Approval of the compensation policy for Mr. Grégoire

-

10,759,416 votes in favour

de ROTALIER, Deputy Chief Executive Officer, for

-

2,286,704 votes against

2023

-

0 abstention

Resolution adopted by:

▪

RESOLUTION NINETEEN

-

13,044,420 votes in favour

Approval of the compensation policy for Directors

-

1,700 votes against

-

0 abstention

▪

RESOLUTION TWENTY

Resolution adopted by:

- 13,044,420 votes in favour

Setting total annual compensation for Directors for

-

1,700 votes against

2023

-

0 abstention

▪ RESOLUTION TWENTY-ONE

Resolution adopted by:

- 11,101,214 votes in favour

Authorisation by the Company to repurchase its own

-

1,944,906 vote against

shares

-

0 abstention

Resolution adopted by:

▪

RESOLUTION TWENTY-TWO

-

13,046,120 votes in favour

Powers for formalities

-

0 vote against

-

0 abstention

  1. After deduction of excluded voting rights

Financial Calendar:

  • Publication of H1 2023 Revenue: 3 August 2023 (after the close of trading).

About Group Equasens

Founded more than 35 years ago, Equasens Group, which now has more than 1,200 employees in Europe, is the leading publisher of software solutions for the healthcare industry in terms of the diversity of its business applications and market share.

Equasens Group's specialised business applications facilitate the day-to-day work of healthcare professionals and their teams, working in private practice, collaborative medical structures or healthcare establishments. The Group also provides comprehensive support to healthcare professionals in the transformation of their profession by developing electronic equipment, digital solutions and healthcare robotics, as well as financing and training adapted to their specific needs.

And reflecting the spirit of its tagline " technology for a more human experience", the Group is a leading provider of interoperability solutions that improve coordination between healthcare professionals, their communications and data exchange resulting in better patient care and a more efficient healthcare system.

Listed on Euronext Paris™ - Compartment A

Indexes: MSCI GLOBAL SMALL CAP - GAÏA Index 2020 - CAC® SMALL and CAC® All-Tradable

Included in the Euronext Tech Leaders segment and the European Rising Tech label

Eligible for the Deferred Settlement Service ("Service à Règlement Différé" - SRD) and equity savings accounts invested in small and mid caps (PEA-PME)

ISIN: FR 0012882389 - Ticker Code: EQS

Press Release 5 July 2023 - Results of the votes - 4

Get all the news about the Equasens Group www.equasens.comand on LinkedIn

CONTACTS

Analyst and Investor Relations:

Chief Administrative and Financial Officer: Frédérique SCHMIDT

Tel. +33 (0)3 83 15 90 67 - frederique.schmidt@equasens.com

Media Relations:

FIN'EXTENSO - Isabelle APRILE

Tel. +33 (0)6 17 38 61 78 - i.aprile@finextenso.fr

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Equasens SA published this content on 05 July 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 05 July 2023 16:13:04 UTC.